This invention provides compounds of Formula (I) or (Ia): ##STR00001## that are useful in the treatment or inhibition of LXR mediated diseases.
Web www.patentalert.com
< Quinoxaline derivatives as PI3 kinase inhibitors
> Inhibitors of Akt activity
> Antibodies to M-CSF
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT